Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Mometasone Furoate*(Mometasone Furoate)

Medicare prescription drug cost, prescriptions and prescribers, 2024

-

Medicare cost

Medicare drug plans spent on Mometasone Furoate* (mometasone furoate) in 2024, for prescriptions and refills.

Medicare cost

-

Prescriptions

-

- per claim

Patients

-

- prescribers

Total spending, 2024

$43.6M

$83.54 per patient

Questions and answers

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Mometasone Furoate* was $43.6M in 2024, after a high of $59.3M in 2022.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Apotex Corp202,958$20.8M
Amneal PharmaceAMRX logoAMRX96,567$9.3M
Cosette Pharmac329,014$6.2M
Padagis228,150$4.5M
Perrigo/PadagisPRGO logoPRGO119,965$2.0M
Aurobindo PharmAUROPHARMA.NS logoAUROPHARMA.NS7,249$695K
Glenmark PharmaGLENMARK.NS logoGLENMARK.NS8,841$183K
Northstar Rx Ll729$14K
Fougera/SandozSDZ.SW logoSDZ.SW274$5,410
Taro Pharm USA68$1,540
Gsms, Inc.18$1,005

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube